Amber Bio Raises $26 Million Seed Financing Co-Led By Playground Global And Andreessen Horowitz To Advance New Rna-Based Gene Editing Platform
Amount Raised
$26 Million
Round Type
Seed
San FranciscoBiotechnologyGeneticsTherapeuticsInvestors
Description
Amber Bio, a biotechnology company pioneering multi-kilobase gene editing platforms to reach previously undruggable diseases, launched today with an oversubscribed $26 million seed financing round co-led by Playground Global and Andreessen Horowitz Bio + Health. Eli Lilly, RDF (Retinal Degeneration Fund), Hummingbird Ventures, and Pillar VC also participated in the round.
Quick answer
Amber Bio raised $26 Million in a Seed round, dated August 3, 2023. Investors: Andreessen Horowitz (a16z) Bio + Health, Pillar VC, Hummingbird Ventures, Rdf, Eli Lilly and Playground Global. Amber Bio is based in San Francisco, California, United States.
- How much did Amber Bio raise?
- Amber Bio raised $26 Million in a Seed round on August 3, 2023.
- Who invested in Amber Bio?
- Andreessen Horowitz (a16z) Bio + Health, Pillar VC, Hummingbird Ventures, Rdf, Eli Lilly and Playground Global are named as investors in this round.
- What does Amber Bio do?
- Amber Bio is crafting the frontier of genetic medicine through biologically inspired design.
- Where is Amber Bio based and how big is it?
- Amber Bio is based in San Francisco, California, United States.
- Who are the decision-makers at Amber Bio?
- Fundz holds 1 contact at Amber Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Amber Bio that raised within 45 days of this round, from Fundz verified event records.
- Lexeo Therapeutics raised an undisclosed amount (Corporate Round) on August 28, 2023.
- Entero Therapeutics raised $1.5M (Seed) on September 14, 2023.
- DalCor Pharmaceuticals raised $80M (Series D) on September 13, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Grit Biotechnology raised $60M (Series B) on September 8, 2023.
- Corteria raised $70M (Funding Round) on September 7, 2023.
Who to call at Amber Bio, and when
A new round usually means Amber Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amber Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amber Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amber Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amber Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Amber Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.